Joanna Chorbińska

MD, PhD candidate, Department of Minimally Invasive and Robotic Urology University Center of Excellence in Urology Wrocław Medical Uniwersity Poland

[YAU Working Group Penile & Testis Cancer @YAUpenile_tesCa]

📢 Reminder!

Have you seen our recent survey?🧑‍🔬🩸

If you’re not a pathologist, please share this with colleagues or pathology team.

Together, we can advance research.
Thank you! 🙏
#Pathology #PenileCancer @Uroweb @ESP_Pathology @eau_yuo @SFPathol @AmerUrological

[Łukasz Nowak @lukasz_t_nowak]

FANS are becoming a standard! Another step forward in providing top-notch care for our patients with urolithiasis! 1550 HU 20 x 17 mm stone removed in 42 min.
11/13 ClearPetra UAS
8.5 Fr Hawk ureteroscope
@wojciechpiotrk1
@bartmalkiewicz
@ChorbinskaJ

[Housen @Housbow]

Amazing Day 3 at #EAU24 @Uroweb

With a presentation of our 🇵🇱 KOL Pr @wojciechpiotrk1

our partner @Varimed_PL

Thank you all for your interest on #ILY_ROBOT

Let's destroy stones 🎮 🦾 in all 🌎

[Łukasz Nowak @lukasz_t_nowak]

Our latest SR and MA "Clinical and Oncological Outcomes Following Percutaneous Cryoablation vs. Partial Nephrectomy for Clinical T1 Renal Tumours: Systematic Review and Meta-Analysis" is now available.
@wojciechpiotrk1
@bartmalkiewicz
@ChorbinskaJ
@f_delgiudice

[Łukasz Nowak @lukasz_t_nowak]

Day with 3D fusion navigation system Navigo by UC-Care combined with BK ultrasound. A precise and fast way to perform MRI targeted transperineal prostate biopsy. #TREXIT
@wojciechpiotrk1
@bartmalkiewicz
@ChorbinskaJ
@Pawel_Kielb
@UC_Care_Medical

[scoffone cesare @scoffonecesare]

T&T2023 Free On line registration here:
https://t.co/0M9cG4moHf

[Łukasz Nowak @lukasz_t_nowak]

A new tool in our endourological armamentarium: micro-PCNL 4.8 Fr, "all-seeing needle" (MicroPerc®).

No bleeding after calyceal puncture, good visibility, effective lithotripsy.

Viable option in selective cases.
@wojciechpiotrk1
@bartmalkiewicz
@ChorbinskaJ

[YAU Working Group Penile & Testis Cancer @YAUpenile_tesCa]

🌟An incredible day at the YAU meeting in #EMUC23 Marseille! 🤝🗣️ Exciting opportunity to connect and discuss our ongoing and future projects in an interdisciplinary way.

#YAU #EMUCMarseille #Collaboration #Penilecancer #Testicularcancer @Uroweb

[Łukasz Nowak @lukasz_t_nowak]

RIRS using 10/12 Fr ClearPetra UAS from WellLead Medical Company.
Hard (1550 HU) and large (2.5 x 2 cm) renal pelvis stone dusted in 46 minutes.
Simply a game changer.

@wojciechpiotrk1
@ChorbinskaJ
@bartmalkiewicz

[Łukasz Nowak @lukasz_t_nowak]

As the Guest Editors, we are pleased to announce a new Special Issue for Biomedicines entitled "Bladder Cancer: From Pathophysiology to Novel Therapeutic Approaches".
https://t.co/4UsIwTy0Uk

[Łukasz Nowak @lukasz_t_nowak]

Annual @EndoPTU meeting. Our video of mini-ECIRS procedure presented by expert @wojciechpiotrk1

@ChorbinskaJ
@bartmalkiewicz

[wojciech_piotr_krajewski @wojciechpiotrk1]

2nd day of 30th annual @EndoPTU meeting! Stone „how do I do miniECIRS” session. @PBryniarski @mzawadzk1 @PrzemyslawZugaj @MarcinJarzemski @lukasz_t_nowak @ChorbinskaJ @ewabres

[Francesco, Del Giudice @f_delgiudice]

Extremely productive week of clinical and research collaboration in #Uro @USK_Wroclaw directed by my close @EAU_YAUrotheli @EAUYAUrology friend @wojciechpiotrk1
The whole spectrum of #lower/ #uppertract #endourology procedures masterly covered. A true @Uroweb #excellence center

[YAU Working Group Penile & Testis Cancer @YAUpenile_tesCa]

HPV found in 45% of penile tumours treated at Haukeland University Hospital, HPV-16 being most common subtype. 5 yrs CSS 70% in HPV+, 83% in HPV -, not independent predictor for survival. HPV remains a risk factor for penile cancer #EAU23 #HPV A0639

[YAU Working Group Penile & Testis Cancer @YAUpenile_tesCa]

MiR371 data on 16 marker-negative stage IIA/B patients (10 seminoma/6 non-seminoma) undergoing primary nsRPLND presented #EAU23, summary by @JoaoPedroLobo89: Metastatic seminoma/non-seminoma in 12 patients, all miR371 positive. MiR371 negative in 3/4 pts without metastases. A0750

[Łukasz Nowak @lukasz_t_nowak]

First, but I hope not last presentation during EAU

@wojciechpiotrk1
@ChorbinskaJ

[Joanna Chorbińska @ChorbinskaJ]

Last Day st EAU 23
Friends & science - perfect combination 💪🏻
See you next year 🫶🏻
@lukasz_t_nowak @wojciechpiotrk1 #EAU2023 #eau23 #urology #medicine

[Housen @Housbow]

D3 at #EAU23 Thank you all for your interest on our ILY Robot.

Warm thank to Pr @wojciechpiotrk1 who did a presentation on ILY.

Let's destroy stones 🎮 🦾

@PusenMedical

#MadeinFrance 🇫🇷
#FursRobot
#Urology
#Endourology

@Uroweb
@AFUrologie
@AmerUrological
@SIU_urology

[YAU Working Group Penile & Testis Cancer @YAUpenile_tesCa]

RA-VEIL in 67 patients in Rajiv Ghandi Cancer Institute #Deli – comparable LoS between CN+ vs CN- group. 85.8% free of complications. 3yr CSS 70.5% in CN+ vs 100% in CN- likely to reflect disease biology. RA-VEIL option to provide local control in CN+ Abstract: A0642 from #EAU23

[YAU Working Group Penile & Testis Cancer @YAUpenile_tesCa]

From 3276 PeCa pts treated from 1990-2020 in the Netherlands, pts with pT2-4 or pN+ are treated more frequently in expert centers. 5-year relative survival was longer in expert centers (86%) compared to non-expert centers (76%, p<0.001). A0645 by Manon Vreeburg @NKI_nl #EAU23